Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study

Completed

Conditions studied: Bladder Cancer

In brief

This is a two-arm, randomized-controlled pilot study with 2 year duration. The "intervention" refers to surveillance based on the European Association of Urology (EAU) guidelines and the "control" refers to surveillance based on the American Urological Association (AUA) guidelines.

Key facts

Study ID

NCT02298998

Run by

The University of Texas Health Science Center at San Antonio

People needed

41

Starts

2013-03-01

Expected to finish

2021-06-07

Last updated by the study team

2021-06-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must have non-muscle invasive low-grade, papillary (Ta) bladder cancer.
• Must have a negative cystoscopy following most recent biopsy.
• Must be able to give informed consent.
• Must be age 18 or older.
• Must be at low- or low-intermediate risk for disease recurrence and progression according to the EAU guidelines.

You may not qualify if…

• Have a history of invasive (>=T1) bladder cancer.
• Have a history of carcinoma-in-situ (CIS).
• Unable to give informed consent.
• < 18 or younger.
• Variant histology (micropapillary, nested variant, non-urothelial cell carcinoma elements).
• Had a surveillance cystoscopy following most recent biopsy.

Where it is running

• The University of Texas Health Science Center — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.